UNSPSC 51385402: Diclonixin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C12H8Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 357591W853, chemically known as 2-(2,3-dichloroanilino)-nicotinic acid. but generally known as diclonixin, which bears US NIH Compound Identifier 208833. European Medicines Agency schedules Diclonixin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07097MIG.

UNSPSC 51385402 Diclonixin is a Commodity code representing pharmaceutical and medical products that state and local governments procure to support public health and emergency response initiatives. Based on recent solicitations, the code encompasses naloxone and drug deactivation systems acquired by county health departments and community health agencies for opioid overdose response, harm reduction, and substance abuse management programs. The buying bodies under this code include county health departments and special-purpose public health districts that manage community health services and emergency preparedness.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bidding deadline was July 26, 2023, at 2:00 pm, with electronic submission required through the county's e-Procurement Portal. Vendors must include all shipping and delivery costs in their proposals, provide unit costs for each line item, maintain workers' compensation and commercial general liability insurance, comply with drug-free workplace certification and E-Verify requirements, and accept a three-month probationary period. The contract includes an initial two-year term with an option for one-year renewal and is potentially funded through FEMA, requiring adherence to federal environmental regulations including the Clean Air Act and Federal Water Pollution Control Act. The procurement does not specify set-aside designations for disadvantaged enterprises.